TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418 | -1.4% | 27,000 | 0.0% | 0.18% | +2.9% |
| Q2 2023 | $424 | -4.7% | 27,000 | 0.0% | 0.17% | -11.3% |
| Q1 2023 | $445 | +5.7% | 27,000 | 0.0% | 0.19% | -1.5% |
| Q4 2022 | $421 | -99.9% | 27,000 | 0.0% | 0.20% | +5.9% |
| Q3 2022 | $350,000 | -8.9% | 27,000 | -1.4% | 0.19% | -5.1% |
| Q2 2022 | $384,000 | -0.8% | 27,372 | +1.4% | 0.20% | +10.7% |
| Q1 2022 | $387,000 | +5.2% | 27,000 | 0.0% | 0.18% | +9.3% |
| Q4 2021 | $368,000 | -26.8% | 27,000 | -12.1% | 0.16% | -32.5% |
| Q3 2021 | $503,000 | -2.7% | 30,700 | 0.0% | 0.24% | -1.2% |
| Q2 2021 | $517,000 | -36.7% | 30,700 | -31.4% | 0.24% | -49.4% |
| Q1 2021 | $817,000 | +0.4% | 44,726 | 0.0% | 0.48% | -9.3% |
| Q4 2020 | $814,000 | +2.0% | 44,726 | 0.0% | 0.53% | -11.8% |
| Q3 2020 | $798,000 | -0.5% | 44,726 | 0.0% | 0.60% | -7.6% |
| Q2 2020 | $802,000 | +18.1% | 44,726 | 0.0% | 0.65% | -3.9% |
| Q1 2020 | $679,000 | -23.0% | 44,726 | 0.0% | 0.68% | +3.8% |
| Q4 2019 | $882,000 | – | 44,726 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |